Financials
Value Q2, 25Q3, 25Q4, 25 TTM Selling/general/admin expenses 3.07 M3.84 M3.7 M — Research & development 3.39 M6.09 M5.72 M — Operating income -4.65 M-8.02 M-7.46 M — Non-Operating Income, Total 26 K98 K94 K — Interest expense, net of interest capitalized ——— — Non-Operating Income, excl. Interest Expenses 37 K132 K94 K — Unusual income/expense -11 K-34 K0 — Pretax income -4.63 M-7.92 M-7.37 M — Equity in earnings ——— — Taxes 0024 K — Non-controlling/minority interest ——— — After tax other income/expense ——— — Net income before discontinued operations -4.63 M-7.92 M-7.39 M — Discontinued operations ——— — Net income -4.63 M-7.92 M-7.39 M — Dilution adjustment ——— — Preferred dividends ——— — Diluted net income available to common stockholders -4.63 M-7.92 M-7.39 M — Basic earnings per share (Basic EPS) -2.02-0.173.63 — Diluted earnings per share (Diluted EPS) -2.02-0.17-0.3 — Average basic shares outstanding 2.29 M46.22 M24.56 M — Diluted shares outstanding 2.29 M46.22 M24.56 M — EBITDA -4.6 M-7.96 M-7.41 M — EBIT -4.65 M-8.02 M-7.46 M — Cost of revenue 1.5 M1.62 M1.96 M — Other cost of goods sold ——— — Depreciation & amortization (cash flow) 55 K54 K55 K —